Navigation Links
DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
Date:4/18/2013

New York, NY (PRWEB) April 18, 2013

The drug safety advocates at DrugRisks.com are alerting of updated legal news on the site for patients who have taken the diabetes drug Actos. A jury could begin deliberations today in a trial accusing Takeda Pharmaceuticals of causing bladder cancer with their diabetes drug Actos***.

DrugRisks is designed to improve the safety of those taking popular prescription drugs like Actos by providing the latest warnings, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice.

The FDA and European Medicines Agency* have warned that taking Actos for longer than one year may be associated with an increased risk of bladder cancer. Regulators in France and Germany have even banned its use**.

DrugRisks has learned as many as 3,000 patients in the U.S. have filed an Actos lawsuit against Takeda Pharmaceuticals over allegations their drug caused bladder cancer***. The first trial is underway for Jack Cooper, a grandfather who is now terminally ill from the disease***.

Now, the resource center has added legal news showing lawyers are finishing their closing arguments and the jury could begin deliberations as soon as Tuesday or Wednesday this week. A decision is expected soon***.

Lawyers continue to help those diagnosed with bladder cancer after taking Actos file claims. Anyone affected is urged to contact the DrugRisks Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of drug injury litigation against large pharmaceutical companies, DrugRisks only recommends lawyers and law firms who have already handled Actos lawsuits.

Visit http://www.DrugRisks.com today for more information on Actos bladder cancer research, side effects and litigation news, or to speak with a lawyer.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos; ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/hu an_pha_detail_000033.jsp&mid=WC0b01ac058001d126
**cbsnews.com/8301-504763_162-20070492-10391704.html
***bloomberg.com/news/2013-04-15/takeda-s-actos-diabetes-drug-tied-to-cancer-jury-is-told.html

Read the full story at http://www.prweb.com/releases/actos-lawsuit-news-2013/settlement-update/prweb10639079.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
2. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
3. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
4. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
5. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
6. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
7. Nia Vardalos Speaks Out on Adoption, Bolsters Legal Support for Abused Children
8. Tariq Drabu Supports Latest Campaign Against Illegal Tooth Whitening
9. Best Injury Lawyers? Time Magazine Includes McDonaldWorley.com Among Nations Legal Leaders
10. Gun retailers take a hard line on illegal firearm sales, UC Davis survey finds
11. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of ... protocols involve many repetitive steps and often scientists require many different versions of ... needed, and results in a lower error rate and cost saving for reagents ...
(Date:3/29/2017)... ... 2017 , ... Hamlin Dental Group, multi-location dental office in North Hollywood ... lasers are safe and effective options, and can be used alone or in conjunction ... quality of care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments ...
(Date:3/29/2017)... ... 29, 2017 , ... Physicians’ Education Resource® (PER®), will host ... conference for clinicians who manage some of the most difficult-to-treat forms of gastrointestinal ... program will be led by co- chairs Dr. John Marshall, chief of Division ...
(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the Microsoft Cloud ... location in Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint ... of Virginia Ralph S. Northam and Mayor of Richmond Levar M. Stoney. , Founded ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education Partners’ ... the field must first improve teacher preparation program design. It then asserts that ... that decades of input- and outcome-based research has failed to improve teacher education. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... value in 2016. There are currently three proton therapy centers in ... more patients. In Italy , the first patients were ...
(Date:3/29/2017)... , March 29, 2017  The Global ... Japanese public-private partnership formed to battle infectious diseases ... totaling US$23 million* that could help deliver a ... of debilitating conditions. This latest ... Phase 3 clinical trial testing a pediatric formulation ...
(Date:3/29/2017)... leader in accelerated orthodontics, OrthoAccel ® Technologies, Inc. ... Manal Ibrahim , Kenji Ojima , Ivan ... microlecture presenters at the AcceleDent ® booth (#3037) ... Session, April 21-25, 2017. Orthodontists and their staff are ... a.m. On the opening morning of AAO exhibitions, Sat., ...
Breaking Medicine Technology: